{"id":30487,"date":"2022-11-02T15:04:49","date_gmt":"2022-11-02T14:04:49","guid":{"rendered":"https:\/\/www.etfworld.com\/ch\/?p=30487"},"modified":"2022-11-02T15:06:06","modified_gmt":"2022-11-02T14:06:06","slug":"vaneck-notiert-einen-neuen-themen-etf-an-der-schweizer-boerse","status":"publish","type":"post","link":"https:\/\/www.etfworld.com\/ch\/vaneck-notiert-einen-neuen-themen-etf-an-der-schweizer-boerse\/","title":{"rendered":"VanEck notiert einen neuen Themen-ETF an der Schweizer B\u00f6rse"},"content":{"rendered":"<div class=\"penci-entry-content entry-content\">\n<p><span id=\"page3R_mcid2\" class=\"markedContent\"><span dir=\"ltr\" role=\"presentation\">Der VanEck Genomics and Healthcare Innovators UCITS ETF bietet Anleger Zugang zu nachhaltigen Unternehmen aus dem Bereich der genomischen und digitalen Gesundheitsf\u00fcrsorge.<\/span><\/span><span id=\"page3R_mcid3\" class=\"markedContent\"><\/span><\/p>\n<p><!--more--><\/p>\n<p><a href=\"http:\/\/etfworld.ch\/newsletter\"><strong>Abonnieren Sie unseren kostenloser Newsletter<\/strong><\/a><\/p>\n<hr \/>\n<p style=\"text-align: center;\"><strong>Von der Redaktion ETFWorld.ch<\/strong><\/p>\n<hr \/>\n<p style=\"text-align: justify;\"><strong><span id=\"page3R_mcid11\" class=\"markedContent\"><span dir=\"ltr\" role=\"presentation\">Martijn Rozemuller, CEO bei VanEck Europe<\/span><\/span><\/strong><\/p>\n<hr \/>\n<p style=\"text-align: justify;\">Genomik-Unternehmen entwickeln neue Wege zur Behandlung von Gesundheitsproblemen wie genetischen Erkrankungen, Krebs und altersbedingten Krankheiten. Hierzu geh\u00f6ren Gentherapien, einschlie\u00dflich Laborger\u00e4te und -dienstleistungen f\u00fcr das Testen und die Codierung, mit denen in erster Linie genetisch verursachte Krankheiten behandelt werden.<\/p>\n<p style=\"text-align: justify;\">Bei der digitalen Gesundheitsf\u00fcrsorge liegt der Fokus auf dem einfachen Zugang zu \u00c4rzten, Physiotherapeuten, Krankenschwestern und Apotheken. Ber\u00fccksichtigt werden Gesch\u00e4ftsbereiche wie Software-Anbieter f\u00fcr Telemedizin und Verwaltung, Online-Apotheken und ambulantes Internet of Things f\u00fcr die Fern\u00fcberwachung von Gesundheitsindikatoren.<\/p>\n<p><strong>VanEck Genomics and Healthcare Innovators UCITS ETF<\/strong><\/p>\n<p>Anlageklasse : Aktien-ETF<\/p>\n<p>ISIN : IE000B9PQW54<\/p>\n<p>Laufende Kosten : 0,35 Prozent<\/p>\n<p>Ertragsverwendung : thesaurierend<\/p>\n<p>Referenzindex : MVIS Global Future Healthcare ESG Index<\/p>\n<p>Quelle: ETFWorld<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Der VanEck Genomics and Healthcare Innovators UCITS ETF bietet Anleger Zugang zu nachhaltigen Unternehmen aus dem Bereich der genomischen und digitalen Gesundheitsf\u00fcrsorge.<\/p>\n","protected":false},"author":4,"featured_media":24817,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"telegram_tosend":false,"telegram_tosend_message":"","telegram_tosend_target":0,"footnotes":"","_wpscp_schedule_draft_date":"","_wpscp_schedule_republish_date":"","_wpscppro_advance_schedule":false,"_wpscppro_advance_schedule_date":"","_wpscppro_dont_share_socialmedia":false,"_wpscppro_custom_social_share_image":0,"_facebook_share_type":"","_twitter_share_type":"","_linkedin_share_type":"","_pinterest_share_type":"","_linkedin_share_type_page":"","_instagram_share_type":"","_medium_share_type":"","_threads_share_type":"","_google_business_share_type":"","_selected_social_profile":[],"_wpsp_enable_custom_social_template":false,"_wpsp_social_scheduling":{"enabled":false,"datetime":null,"platforms":[],"status":"template_only","dateOption":"today","timeOption":"now","customDays":"","customHours":"","customDate":"","customTime":"","schedulingType":"absolute"},"_wpsp_active_default_template":true},"categories":[5],"tags":[117,317],"class_list":["post-30487","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-etf-schweiz","tag-etf","tag-vaneck"],"blocksy_meta":{"styles_descriptor":{"styles":{"desktop":"","tablet":"","mobile":""},"google_fonts":[],"version":6}},"_links":{"self":[{"href":"https:\/\/www.etfworld.com\/ch\/wp-json\/wp\/v2\/posts\/30487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.etfworld.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.etfworld.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.etfworld.com\/ch\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.etfworld.com\/ch\/wp-json\/wp\/v2\/comments?post=30487"}],"version-history":[{"count":2,"href":"https:\/\/www.etfworld.com\/ch\/wp-json\/wp\/v2\/posts\/30487\/revisions"}],"predecessor-version":[{"id":30489,"href":"https:\/\/www.etfworld.com\/ch\/wp-json\/wp\/v2\/posts\/30487\/revisions\/30489"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.etfworld.com\/ch\/wp-json\/wp\/v2\/media\/24817"}],"wp:attachment":[{"href":"https:\/\/www.etfworld.com\/ch\/wp-json\/wp\/v2\/media?parent=30487"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.etfworld.com\/ch\/wp-json\/wp\/v2\/categories?post=30487"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.etfworld.com\/ch\/wp-json\/wp\/v2\/tags?post=30487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}